Using Low-Cost Virtual Reality Simulation to Build Surgical Capacity for Cervical Cancer Treatment.
Journal
Journal of global oncology
ISSN: 2378-9506
Titre abrégé: J Glob Oncol
Pays: United States
ID NLM: 101674751
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
entrez:
10
5
2019
pubmed:
10
5
2019
medline:
21
7
2020
Statut:
ppublish
Résumé
Worldwide, more than 80% of people diagnosed with cancer will require surgery during their disease course, but only 5% to 20% of low- and middle-income countries have access to safe, affordable, and timely surgery. Developing surgical oncology skills requires significant time and mentoring. Virtual reality (VR) simulators can reduce the time required to master surgical procedures but are prohibitively expensive. We sought to determine whether a VR simulator using low-cost computer gaming equipment could train novice surgeons in Africa to perform a virtual radical abdominal (open) hysterectomy (RAH). Our RAH VR simulator used the Oculus Rift (Oculus VR, Menlo Park, CA), a VR headset with hand controllers that costs less than $1,500. Surgical novices learned to perform five key steps of a virtual RAH. We measured and identified predictors of movement and time efficiency for the simulation. Ten novice surgeons in Lusaka, Zambia, enrolled in the study. Movement and time efficiency greatly improved over time. Independent predictors of movement efficiency were number of simulations, surgical experience, and time since college graduation. Independent predictors of time efficiency were number of simulations, surgical experience, days between simulation sessions, age, sex, and an interaction between number of simulations and surgical experience. Low-cost VR may be an effective tool to help surgical novices learn complex surgical oncology procedures. If learning to perform VR surgical procedures with low-cost hardware leads to faster mastery of surgical procedures in the operating room, low-cost VR may represent one of the solutions to increasing access to surgical cancer care globally.
Identifiants
pubmed: 31070982
doi: 10.1200/JGO.18.00263
pmc: PMC6550092
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-7Subventions
Organisme : Medical Research Council
ID : MR/P025420/1
Pays : United Kingdom
Références
Surg Endosc. 2003 Jul;17(7):1082-5
pubmed: 12728373
J Surg Res. 2015 Aug;197(2):231-5
pubmed: 25840488
Lancet Oncol. 2015 Sep;16(11):1193-224
pubmed: 26427363
Am J Obstet Gynecol. 2002 Apr;186(4):836-42
pubmed: 11967517
N Engl J Med. 2018 Nov 15;379(20):1905-1914
pubmed: 30379613
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457
pubmed: 28223433
Simul Healthc. 2011 Aug;6(4):197-203
pubmed: 21527870
Obstet Gynecol. 2015 Sep;126(3):559-68
pubmed: 26244537
Ann Surg. 2005 Feb;241(2):364-72
pubmed: 15650649
Ecancermedicalscience. 2019 Mar 18;13:910
pubmed: 31123493
Acad Med. 2004 Oct;79(10 Suppl):S70-81
pubmed: 15383395
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
J Thorac Cardiovasc Surg. 2013 Jun;145(6):1453-8; discussion 1458-9
pubmed: 23499474
Surg Endosc. 2006 Sep;20(9):1460-6
pubmed: 16823649
Ann Surg. 2014 Mar;259(3):443-8
pubmed: 24503910
Br J Surg. 2004 Feb;91(2):146-50
pubmed: 14760660
BMJ. 2009 May 14;338:b1802
pubmed: 19443914
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
J Clin Anesth. 2014 Nov;26(7):530-8
pubmed: 25439416
N Engl J Med. 2018 Nov 15;379(20):1895-1904
pubmed: 30380365
Ann Surg. 2002 Oct;236(4):458-63; discussion 463-4
pubmed: 12368674
Am J Obstet Gynecol. 2007 Nov;197(5):541.e1-5
pubmed: 17980202